{
    "2021-03-15": [
        [
            {
                "time": "2023-10-18",
                "original_text": "New Zolgensma data demonstrate age-appropriate development when used early, real-world benefit in older children and durability 5+ years post-treatment",
                "features": {
                    "keywords": [
                        "Zolgensma",
                        "age-appropriate development",
                        "real-world benefit",
                        "durability",
                        "5+ years post-treatment"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}